Skip to main content
2024 CRT Conference Main banner

Late-Breaking

Late-Breaking Artificial Intelligence Clinical Trials [Non-CME]

Late-Breaking Artificial Intelligence Clinical Trials [Non-CME]

Monday, March 11, 2024
8:00 AM - 9:00 AM ET

    Moderator(s)

  • Ori Ben-Yehuda, MD

    Professor of Medicine
    University of California, San Diego
    La Jolla, California, United States

  • Justin Davies, MD, PhD

    Cardiologist
    Imperial College London
    London, England, United Kingdom

  • Chaim Lotan, MD

    Director Heart Institute
    Hadassah-Hebrew University Medical Center
    Jerusalem, Israel

    • Panel Discussant(s)

  • Federico Asch, MD

    Director, Cardiovascular Core Labs and Cardiac Imaging Research
    MedStar Health Research Institute
    Washington, District of Columbia, United States

  • Gary Gershony, MD, FACC, FSCAI, FAHA, FRCPC

    Interventional Cardiologist
    John Muir Health Cardiovascular Institute
    San Francisco, California, United States

  • C. Michael Gibson, MD

    Professor of Medicine
    Beth Israel Deaconess Medical Center
    Boston, Massachusetts, United States

  • David Kong, MD, AM, DMT

    Associate Professor of Medicine
    Duke University
    Durham, North Carolina, United States

Disclosure(s):
Ori Ben-Yehuda, MD: Bioventrix, Inc: Consultant (Ongoing); Cardiovalve: Advisor (Ongoing), Consultant (Ongoing)
Justin E. Davies, MD, PhD: No relationships to disclose
Chaim Shaul Lotan, MD: No relationships to disclose
Federico M. Asch, MD: No relationships to disclose
C. Michael Gibson, MD: Absolutys: Shareholder (Ongoing); Angel Medical Systems, Inc.: Consultant (Ongoing); AstraZeneca Pharmaceuticals: Consultant (Ongoing); Bayer HealthCare: Consultant (Ongoing); Beren Therapeutics: Consultant (Ongoing); Bioclinica: Consultant (Ongoing); BOEHRINGER INGELHEIM IT.SpA.: Consultant (Ongoing); Boston Clinical Research Institute: Consultant (Ongoing), Owner/Co-Owner Founder/Co-Founder (Ongoing); Boston Scientific: Consultant (Ongoing); Bristol Meyers Squibb: Consultant (Ongoing); Cardiovascular Research Foundation: Consultant (Ongoing); CeleCor Therapeutics: Consultant (Ongoing); CSL-Behring: Consultant (Ongoing), Grant/Research Support (Ongoing); Duke Clinical Research Institute: Consultant (Ongoing); Dyad Medical: Shareholder (Ongoing); Esperion: Consultant (Ongoing); EXCITE International: Advisor (Ongoing); Fortress Biotech: Consultant (Ongoing), Consultant (Ongoing), Shareholder (Ongoing), Shareholder (Ongoing); Gilead: Consultant (Ongoing); Inari: Consultant (Ongoing); Janssen Research & Development LLC: Consultant (Ongoing), Research Grant (includes principal investigator, collaborator or consultant and pending grants as well as grants already received) (Ongoing); Johnson & Johnson: Consultant (Ongoing), Grant/Research Support (Ongoing); MashUP MD: Consultant (Ongoing); MD Magazine: Consultant (Ongoing); Merck Pharmaceuticals: Consultant (Ongoing); MicroPort Medical: Consultant (Ongoing); MJH Life Sciences: Consultant (Ongoing); New Amsterdam Pharma: Consultant (Ongoing); nference: Shareholder (Ongoing); Novartis Pharmaceuticals: Consultant (Ongoing); NovoNordisk: Consultant (Ongoing); PERT Consortium: Consultant (Ongoing); Pfizer: Consultant (Ongoing); PhaseBio: Consultant (Ongoing); plx pharma: Consultant (Ongoing); Revance Therapeutics: Consultant (Ongoing); Samsung: Consultant (Ongoing); SCAD Alliance: Consultant (Ongoing); SCAI: Consultant (Ongoing); SFJ: Consultant (Ongoing); Somahlution/Marizyme: Consultant (Ongoing); UpToDate in Cardiovascular Medicine: Royalties (Ongoing); Vecutra: Consultant (Ongoing); WebMD: Consultant (Ongoing); Woman As One: Consultant (Ongoing)
David F. Kong, MD, AM, DMT: No financial relationships to disclose

Presentations:

  • 8:00 AM - 8:10 AM ET
    Artificial Intelligence-Derived Automated Intravascular Ultrasound-Based Calcium Score to Predict Stent (Under-)Expansion in Severely Calcified Lesions

    Speaker: Saurav Chatterjee, MD – Long Island Jewish Hospital/Northwell Health

  • 8:10 AM - 8:15 AM ET
    Panel Discussion
  • 8:15 AM - 8:25 AM ET
    Artificial Intelligence System for Identifying and Notifying Hazardous Situations in the Catheterization Laboratory

    Speaker: Yair Feld, MD, PhD – Tzafon Medical Center (Poriya)

  • 8:25 AM - 8:30 AM ET
    Panel Discussion
  • 8:30 AM - 8:40 AM ET
    ECGio – An AI Algorithm to Predict the Presence and Severity of Flow-Limiting CAD Using a Standard 12-Lead ECG

    Speaker: Michael Leasure – HEARTio

  • 8:40 AM - 8:45 AM ET
    Panel Discussion
  • 8:45 AM - 8:55 AM ET
    4TAVR - A Fully Automated Cloud-Based AI-Driven Pre-Procedural TAVR Planning Software

    Speaker: Moritz C. Wyler von Ballmoos, MD, PhD, MPH – Texas Health Resources & TCU

  • 8:55 AM - 9:00 AM ET
    Panel Discussion
  • 9:00 AM ET
    Adjourn